Estrogen plus progestin was not effective for long-term secondary prevention of coronary heart disease in postmenopausal women

Atkins, David
January 2003
ACP Journal Club;Jan/Feb2003, Vol. 138 Issue 1, p6
Academic Journal
Presents a study which investigated the effectiveness of estrogen plus progestin for long-term secondary prevention of coronary heart disease in postmenopausal women. Description of the clinical characteristics of patients; Patient intervention; Outcome measures.


Related Articles

  • Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study. Grodstein, Francine; Manon, JoAnn E.; Stampfer, Meir J. // Annals of Internal Medicine;7/3/2001, Vol. 135 Issue 1, p1 

    Discusses results of a study on the effectiveness of postmenopausal hormone use in the secondary prevention of coronary events. Patient characteristics; Decreasing recurrence of major coronary heart disease events with increasing duration of hormone use; Absence of difference between users of...

  • Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy. Hlatky, Mark A.; Boothroyd, Derek; Vittinghoff, Eric; Sharp, Penny; Whooley, Mary A. // JAMA: Journal of the American Medical Association;2/6/2002, Vol. 287 Issue 5, p591 

    Presents a study to determine the effect on quality of life of estrogen plus progestin therapy used as secondary prevention in women with coronary artery disease. Context; Objective; Design, setting, and participants; Intervention; Main outcome measures; Results; Conclusion that hormone therapy...

  • Should all postmenopausal women receive estrogen? No easy answers.  // Modern Medicine;Apr94, Vol. 62 Issue 4, p32 

    Discusses whether physicians should routinely prescribe estrogen for post-menopausal women to ward off coronary heart disease (CHD). Absence of randomized prospective trial to recommend estrogen for CHD; Lower risk of CHD among estrogen users.

  • Cardiovascular protection extends to women who use progestin with estrogen.  // Modern Medicine;Dec96, Vol. 64 Issue 12, p22 

    Discusses a study conducted by physician Francine Grodstein and colleagues which revealed that estrogen therapies that include progestin provide a degree of protection against heart disease that is similar to that of estrogen alone. Effectiveness of progestin and estrogen in lowering incidence...

  • HRT and CHD: Balancing risk and suggested benefit. Kaplan, Deborah; Wenger, Nanette K. // Patient Care;10/30/2000, Vol. 34 Issue 20, p43 

    Reports on the use of estrogen therapy to protect women against coronary heart disease. Prevention of the development of atherosclerosis; Effect of estrogen on hepatic gene expression; Mediation for short-term coronary vasodilation.

  • Non-genomic effect of 17 β estradiol in the endothelial domination role via nitric oxide in the aorta of guinea pig: study in HUVECs culture and bioassay. Ratnawati, R.; Widodo, M. A.; Permatasari, N. // Proceedings of the Physiological Society;2013, p940P 

    Background: There were some non-linier doses, low usefulness and disadvantages resulted from epidemiological studies using Estrogen Replacement therapy as prevention or active treatment in coronary Vascular Diseases. In vitro studies also showed that the increase of the dose of Estrogen used it...

  • NIH Findings: Controversy of Hormone Replacement Therapy. Sztykowski, Tadeusz; Burke, Robert E. // American Acupuncturist;Fall2002, Vol. 28, p16 

    Focuses on the controversy behind the use of combined estrogen and progestin in healthy menopausal women. Examination of the effect of Prempro on the prevention of heart disease; Association of the effects with the risk of breast and colon cancer; Decrease of libido among the menopausal women.

  • Study confirms value of progestin-estrogen combination.  // Mayo Clinic Health Letter;May1996, Vol. 14 Issue 5, p4 

    Presents information from a study on the value of progestin and estrogen. Progestin taken with estrogen offsets the risk of uterine cancer; Uses of estrogen; What progestin is.

  • Estrogen plus progestin increased coronary heart disease and breast cancer events in postmenopausal women. Lowe, Julia // ACP Journal Club;Sep/Oct2002, Vol. 137 Issue 2, p41 

    Presents information on a study that investigated the risks and benefits of estrogen plus progestin in healthy postmenopausal women. Design of the study; Analysis of the incidence of diseases between the placebo-controlled trial versus estrogen plus progestin; Rate of unfavorable and favorable...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics